Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-17-001808
Filing Date
2017-03-15
Accepted
2017-03-15 09:29:35
Documents
4
Effectiveness Date
2017-03-15

Document Format Files

Seq Description Document Type Size
1 S-8 acrs_currents8.htm S-8 161615
2 EX-5.1 acrs_ex51.htm EX-5.1 17457
3 EX-23.1 acrs_ex231.htm EX-23.1 4208
4 GRAPHIC acrsex51001.jpg GRAPHIC 2651
  Complete submission text file 0001558370-17-001808.txt   188062
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216703 | Film No.: 17690030
SIC: 2834 Pharmaceutical Preparations